+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Asia Pacific Cell Therapy Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Therapy Type, Product, Technology, Application, and End User, and Country- Product Image
Asia Pacific Cell Therapy Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Therapy Type, Product, Technology, Application, and End User, and Country- Product Image
Sale

Asia Pacific Cell Therapy Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Therapy Type, Product, Technology, Application, and End User, and Country

  • PDF Icon

    Report

  • 108 Pages
  • February 2021
  • Region: Asia Pacific
  • The Insight Partners
  • ID: 5295103
UP TO OFF until Dec 31st 2024
Description Jump to:
Cell Therapy Market for Autologous Segment to Grow at Fastest CAGR during Forecast Period

According to our new market research study on “Cell Therapy Market to 2027 - Asia Pacific Analysis and Forecast - by Product Type, and End Use,” the market is expected to reach US$ 1,366.0 million by 2027 from US$ 2,449.8 million in 2019. The market is estimated to grow at a CAGR of 7.7% from 2020-2027. The report highlights trends prevailing in the Asia Pacific cell therapy Market and the drivers and restraints pertaining to the market growth.

Autologous cells propose several benefits to patients, including lowering the risk of immuno-rejection and the potential for personalized medicine. Autologous therapies are tailor made products for each patient. In autologous therapies, the cells obtained from the patient are processed on-site at the clinic or hospital. These therapies are not directed as a biologic product and not developed under Good Manufacturing Practice (GMP), but rather, the devices used to process are regulated. For instance, a RECELL equipment used to make autologous Regenerative Epidermal Suspension for direct application to acute partial-thickness thermal burn wounds. Biologic cell-based therapies to cure several diseases, like cancer, neuro disorder, and skin disease, to name a few. Many healthcare technology start-ups are active in the field of personalized cell therapy to cure diseases. For instance, in 2019, Aspen Neuroscience received US$6.5 Million seed funding to develop personalized and autologous cell therapy for Parkinson’s disease.

Vericel Corporation, MEDIPOST, NuVasive, Inc., Mesoblast Limited, JCR Pharmaceuticals Co. Ltd., Smith & Nephew, Bristol-Myers Squibb Company, Cells for Cells, Stemedica Cell Technologies, Inc, Castle Creek Biosciences, Inc. are among the leading companies operating in the Cell Therapy Market.

The report segments Asia Pacific Cell Therapy market as follows:

By Therapy Type
  • Allogeneic
  • Autologou

By Product
  • Consumables
  • Equipment
  • Systems and Softwar

By Technology
  • Viral Vector Technology
  • Genome Editing Technology
  • Somatic Cell Technology
  • Cell Immortalization Technology
  • Cell Plasticity Technology
  • Three-Dimensional Technolog

By Application
  • Oncology
  • Cardiovascular
  • Orthopedic
  • Wound Management
  • Other Application

By End User
  • Research Institutes
  • Hospitals
  • Other

By Country
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC


Reasons to Buy
  • To understand the Asia Pacific Cell Therapy market landscape and identify market segments that are most likely to guarantee a strong return
  • Stay ahead of the race by comprehending the ever-changing competitive landscape for the Asia Pacific Cell Therapy market
  • Efficiently plan M&A and partnership deals in the Asia Pacific Cell Therapy market by identifying market segments with the most promising probable sales
  • Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form the Asia Pacific Cell Therapy market
  • Obtain market revenue forecast for market by various segments from 2019 to 2027 in the region.

Table of Contents

1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Cell Therapy Market - By Therapy Type
1.3.2 Asia Pacific Cell Therapy Market - By Product
1.3.3 Asia Pacific Cell Therapy Market - By Technology
1.3.4 Asia Pacific Cell Therapy Market - By Application
1.3.5 Asia Pacific Cell Therapy Market - By End User
1.3.6 Asia Pacific Cell Therapy Market - By Country
2. Cell Therapy Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Cell therapy- Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Asia Pacific- PEST Analysis
4.3 Expert Opinions
5. Asia Pacific Cell Therapy Market - Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Increasing Prevalence of Chronic Diseases
5.1.2 Rising Adoption of Regenerative Medicines
5.1.3 Increasing Number of Approvals for Cell-Based Therapies
5.2 Key Market Restraints
5.2.1 High Cost of Cell Therapy Manufacturing
5.3 Key Market Opportunities
5.3.1 Increasing Adoption of Cell Therapy in Developing Regions
5.4 Future Trends
5.4.1 Shift Toward Automated Cell Therapy Manufacturing
5.5 Impact Analysis of Drivers and Restraints
6. Cell therapy Market - Asia Pacific Analysis
6.1 Asia Pacific Cell therapy Market Revenue Forecast And Analysis
6.2 Market Positioning
7. Cell therapy Market Analysis - By Therapy Type
7.1 Overview
7.2 Cell therapy Market Revenue Share, by Therapy Type (2019 and 2027)
7.3 Allogeneic
7.3.1 Overview
7.3.2 Allogeneic: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
7.4 Autologous
7.4.1 Overview
7.4.2 Autologous: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
8. Cell therapy Market Analysis - By Product
8.1 Overview
8.2 Cell therapy Market Revenue Share, by Product (2019 and 2027)
8.3 Consumables
8.3.1 Overview
8.3.2 Consumables: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
8.4 Equipment
8.4.1 Overview
8.4.2 Equipment: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
8.5 Systems and Software
8.5.1 Overview
8.5.2 Systems and Software: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
9. Cell therapy Market Analysis - By Technology
9.1 Overview
9.2 Cell therapy Market Revenue Share, by Technology (2019 and 2027)
9.3 Viral Vector Technology
9.3.1 Overview
9.3.2 Viral Vector Technology: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
9.4 Genome Editing Technology
9.4.1 Overview
9.4.2 Genome Editing Technology: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
9.5 Somatic Cell Technology
9.5.1 Overview
9.5.2 Somatic Cell Technology: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
9.6 Cell Immortalization Technology
9.6.1 Overview
9.6.2 Cell Immortalization Technology: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
9.7 Cell Plasticity Technology
9.7.1 Overview
9.7.2 Cell Plasticity Technology: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
9.8 Three-Dimensional Technology
9.8.1 Overview
9.8.2 Three-Dimensional Technology: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
10. Cell therapy Market Analysis - By Application
10.1 Overview
10.2 Cell therapy Market Revenue Share, by Application (2019 and 2027)
10.3 Oncology
10.3.1 Overview
10.3.2 Oncology: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
10.4 Cardiovascular
10.4.1 Overview
10.4.2 Cardiovascular: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
10.5 Orthopedic
10.5.1 Overview
10.5.2 Orthopedic: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
10.6 Wound Management
10.6.1 Overview
10.6.2 Wound Management: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
10.7 Other Applications
10.7.1 Overview
10.7.2 Other Applications: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
11. Cell therapy Market Analysis - By End User
11.1 Overview
11.2 Cell therapy Market Share, by End User, 2019 and 2027, (%)
11.3 Hospitals
11.3.1 Overview
11.3.2 Hospitals: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
11.4 Research Institutes
11.4.1 Overview
11.4.2 Research Institutes: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
11.5 Others
11.5.1 Overview
11.5.2 Others: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
12. Cell therapy Market - Geographic Analysis
12.1 Asia Pacific: Cell Therapy Market
12.1.1 Overview
12.1.2 Asia Pacific: Cell Therapy Market - Revenue and Forecast to 2027 (USD Million)
12.1.3 Asia Pacific: Cell Therapy Market, by Therapy Type, 2018-2027 (USD Million)
12.1.4 Asia Pacific: Cell Therapy Market, by Product, 2018-2027 (USD Million)
12.1.5 Asia Pacific: Cell Therapy Market, by Technology 2018-2027 (USD Million)
12.1.6 Asia Pacific: Cell Therapy Market, by Application 2018-2027 (USD Million)
12.1.7 Asia Pacific: Cell Therapy Market, by End User, 2018-2027 (USD Million)
12.1.8 Asia Pacific: Cell Therapy Market, by Country, 2019 & 2027 (%)
12.1.9 China: Cell Therapy Market - Revenue and Forecast to 2027 (USD Million)
12.1.9.1 China: Cell Therapy Market - Revenue and Forecast to 2027 (USD Million)
12.1.9.2 China: Cell Therapy Market, by Therapy Type, 2018-2027 (USD Million)
12.1.9.3 China: Cell Therapy Market, by Product, 2018-2027 (USD Million)
12.1.9.4 China: Cell Therapy Market, by Technology 2018-2027 (USD Million)
12.1.9.5 China: Cell Therapy Market, by Application 2018-2027 (USD Million)
12.1.9.6 China: Cell Therapy Market, by End User, 2018-2027 (USD Million)
12.1.10 Japan: Cell Therapy Market - Revenue and Forecast to 2027 (USD Million)
12.1.10.1 Japan: Cell Therapy Market - Revenue and Forecast to 2027 (USD Million)
12.1.10.2 Japan: Cell Therapy Market, by Therapy Type, 2018-2027 (USD Million)
12.1.10.3 Japan: Cell Therapy Market, by Product, 2018-2027 (USD Million)
12.1.10.4 Japan: Cell Therapy Market, by Technology 2018-2027 (USD Million)
12.1.10.5 Japan: Cell Therapy Market, by Application 2018-2027 (USD Million)
12.1.10.6 Japan: Cell Therapy Market, by End User, 2018-2027 (USD Million)
12.1.11 India: Cell Therapy Market - Revenue and Forecast to 2027 (USD Million)
12.1.11.1 India: Cell Therapy Market - Revenue and Forecast to 2027 (USD Million)
12.1.11.2 India: Cell Therapy Market, by Therapy Type, 2018-2027 (USD Million)
12.1.11.3 India: Cell Therapy Market, by Product, 2018-2027 (USD Million)
12.1.11.4 India: Cell Therapy Market, by Technology 2018-2027 (USD Million)
12.1.11.5 India: Cell Therapy Market, by Application 2018-2027 (USD Million)
12.1.11.6 India: Cell Therapy Market, by End User, 2018-2027 (USD Million)
12.1.12 South Korea: Cell Therapy Market - Revenue and Forecast to 2027 (USD Million)
12.1.12.1 South Korea: Cell Therapy Market - Revenue and Forecast to 2027 (USD Million)
12.1.12.2 South Korea: Cell Therapy Market, by Therapy Type, 2018-2027 (USD Million)
12.1.12.3 South Korea: Cell Therapy Market, by Product, 2018-2027 (USD Million)
12.1.12.4 South Korea: Cell Therapy Market, by Technology 2018-2027 (USD Million)
12.1.12.5 South Korea: Cell Therapy Market, by Application 2018-2027 (USD Million)
12.1.12.6 South Korea: Cell Therapy Market, by End User, 2018-2027 (USD Million)
12.1.13 Australia: Cell Therapy Market - Revenue and Forecast to 2027 (USD Million)
12.1.13.1 Australia: Cell Therapy Market - Revenue and Forecast to 2027 (USD Million)
12.1.13.2 Australia: Cell Therapy Market, by Therapy Type, 2018-2027 (USD Million)
12.1.13.3 Australia: Cell Therapy Market, by Product, 2018-2027 (USD Million)
12.1.13.4 Australia: Cell Therapy Market, by Technology 2018-2027 (USD Million)
12.1.13.5 Australia: Cell Therapy Market, by Application 2018-2027 (USD Million)
12.1.13.6 Australia: Cell Therapy Market, by End User, 2018-2027 (USD Million)
13. Impact of COVID-19 Pandemic on Asia Pacific Cell Therapy Market
13.1 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
14. Company Profiles
14.1 Vericel Corporation
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 MEDIPOST
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 NuVasive, Inc.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Mesoblast Limited
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 JCR Pharmaceuticals Co. Ltd.
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Smith & Nephew
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Bristol-Myers Squibb Company
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Cells for Cells
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Stemedica Cell Technologies, Inc
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Castle Creek Biosciences, Inc.
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About the Publisher
15.2 Glossary of Terms
List of Tables
Table 1. Asia Pacific Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2027 (USD Million)
Table 2. Asia Pacific Cell Therapy Market, by Product- Revenue and Forecast to 2027 (USD Million)
Table 3. Asia Pacific Cell Therapy Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 4. Asia Pacific Cell Therapy Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 5. Asia Pacific Cell Therapy Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 6. China Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2027 (USD Million)
Table 7. China Cell Therapy Market, by Product- Revenue and Forecast to 2027 (USD Million)
Table 8. China Cell Therapy Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 9. China Cell Therapy Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 10. China Cell Therapy Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 11. Japan Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2027 (USD Million)
Table 12. Japan Cell Therapy Market, by Product- Revenue and Forecast to 2027 (USD Million)
Table 13. Japan Cell Therapy Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 14. Japan Cell Therapy Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 15. Japan Cell Therapy Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 16. India Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2027 (USD Million)
Table 17. India Cell Therapy Market, by Product- Revenue and Forecast to 2027 (USD Million)
Table 18. India Cell Therapy Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 19. India Cell Therapy Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 20. India Cell Therapy Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 21. South Korea Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2027 (USD Million)
Table 22. South Korea Cell Therapy Market, by Product- Revenue and Forecast to 2027 (USD Million)
Table 23. South Korea Cell Therapy Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 24. South Korea Cell Therapy Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 25. South Korea Cell Therapy Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 26. Australia Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2027 (USD Million)
Table 27. Australia Cell Therapy Market, by Product- Revenue and Forecast to 2027 (USD Million)
Table 28. Australia Cell Therapy Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 29. Australia Cell Therapy Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 30. Australia Cell Therapy Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 31. Glossary of Terms, Cell therapy Market
List of Figures
Figure 1. Cell Therapy Market Segmentation
Figure 2. Cell Therapy Market, By Region
Figure 3. Asia Pacific Cell Therapy Market Overview
Figure 4. The Autologous Segment Is Expected To Grow Faster By Therapy Type Segment In Cell therapy Market
Figure 5. Asia Pacific Cell therapy Market, Industry Landscape
Figure 6. Asia pacific PEST Analysis
Figure 7. Cell Therapy Market Impact Analysis of Driver and restraint
Figure 8. Asia Pacific Cell therapy Market - Revenue Forecast And Analysis - 2019- 2027
Figure 9. Asia Pacific Cell therapy Market - By Country Forecast and Analysis - 2019- 2027
Figure 10. Cell therapy Market Revenue Share, by Therapy Type (2019 and 2027)
Figure 11. Allogeneic: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 12. Autologous: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 13. Cell therapy Market Revenue Share, by Product (2019 and 2027)
Figure 14. Consumables: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 15. Equipment: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 16. Systems and Software: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 17. Cell therapy Market Revenue Share, by Technology (2019 and 2027)
Figure 18. Viral Vector Technology: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 19. Genome Editing Technology: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 20. Somatic Cell Technology: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 21. Cell Immortalization Technology: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 22. Cell Plasticity Technology: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 23. Three-Dimensional Technology: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 24. Cell therapy Market Revenue Share, by Application (2019 and 2027)
Figure 25. Oncology: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 26. Cardiovascular: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 27. Orthopedic: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 28. Wound Management: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 29. Other Applications: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 30. Cell therapy Market Share, by End User, 2019 and 2027 (%)
Figure 31. Hospitals Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 32. Research Institutes: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 33. Others: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 34. Asia Pacific: Cell Therapy Market, by Key Country - Revenue (2019) (USD Million)
Figure 35. Asia Pacific Cell Therapy Market Revenue and Forecast to 2027 (USD Million)
Figure 36. China: Cell Therapy Market - Revenue and Forecast to 2027 (USD Million)
Figure 37. Japan: Cell Therapy Market - Revenue and Forecast to 2027 (USD Million)
Figure 38. India: Cell Therapy Market - Revenue and Forecast to 2027 (USD Million)
Figure 39. South Korea: Cell Therapy Market - Revenue and Forecast to 2027 (USD Million)
Figure 40. Australia: Cell Therapy Market - Revenue and Forecast to 2027 (USD Million)
Figure 41. Impact of COVID-19 Pandemic in Asia Pacific Country Markets

Companies Mentioned

  • Vericel Corporation
  • MEDIPOST
  • NuVasive, Inc.
  • Mesoblast Limited
  • JCR Pharmaceuticals Co. Ltd.
  • Smith & Nephew
  • Bristol-Myers Squibb Company
  • Cells for Cells
  • Stemedica Cell Technologies, Inc
  • Castle Creek Biosciences, Inc.

Related Topics

Related Reports

Cell & Gene Therapy Manufacturing Services Market by Type, Indication, Application, End-User - Global Forecast 2025-2030 - Product Image

Cell & Gene Therapy Manufacturing Services Market by Type, Indication, Application, End-User - Global Forecast 2025-2030

  • Report
  • 197 Pages
  • Global
From
Cell Therapy - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Cell Therapy - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Cell Therapy Market Size, Share & Trends Analysis Report by Therapy Type (Autologous (Stem Cell Therapies, Non-stem Cell Therapies), Allogeneic), Therapeutic Area, Region, and Segment Forecasts, 2024-2030 - Product Image

Cell Therapy Market Size, Share & Trends Analysis Report by Therapy Type (Autologous (Stem Cell Therapies, Non-stem Cell Therapies), Allogeneic), Therapeutic Area, Region, and Segment Forecasts, 2024-2030

  • Report
  • 110 Pages
  • Global
From
Autologous Cell Therapy Market Size, Share & Trends Analysis Report By Application (Cancer, Neurodegenerative Disorders), Source (Bone Marrow, Mesenchymal Stem Cells), By End-use, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Autologous Cell Therapy Market Size, Share & Trends Analysis Report By Application (Cancer, Neurodegenerative Disorders), Source (Bone Marrow, Mesenchymal Stem Cells), By End-use, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 85 Pages
  • Global
From
Cell Therapy Market by Cell Type, Therapy Type, Application, End-User - Global Forecast 2025-2030 - Product Image

Cell Therapy Market by Cell Type, Therapy Type, Application, End-User - Global Forecast 2025-2030

  • Report
  • 194 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.